Clinical Trial Update: Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared carvedilol and atenolol for anti-anginal and metabolic effects in patients with stable angina pectoris; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina Pectoris

Drugs mentioned

• Coreg (carvedilol)
• TENORMIN (ATENOLOL)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Stable Angina Pectoris | Phase 4 | Status: COMPLETED